Methods of promoting bone growth in mammals comprising administration of modified parathyroid hormone
US5457092A · kind A · utility
18Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 1993 |
| Grant date | Oct 10, 1995 |
| Priority date | — |
| Expiry date | Sep 13, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
pPTH, bPTH or hPTH is modified by deletions from the natural C- and/or N-terminus. The modified compounds are useful active ingredients in therapeutic compositions. The therapeutic compositions do not stimulate renal adenylate cyclase but, rather, effect chondrocyte proliferation, that is to say, they exhibit a mitogenic and bone-specific effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.